SCOLR Pharma, Inc. (DDD) said it submitted Abbreviated New Drug Application for a 120 milligram 12-hour pseudoephedrine tablet to the Food and Drug Administration. The company noted that this is the first application submitted by SCOLR based on its CDT platform.
Pseudoephedrine is an active ingredient in Allegra D, Sudafed PSE, Claritin D, Zyrtec D and other over-the-counter and prescription products as a decongestant.
Further, the company said it expects to complete the ibuprofen trial late this year. If approved, the company believes its ibuprofen product would be the first and only OTC 12-hour, extended-release ibuprofen product on the market in the U.S.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.